Swiss Industry Makes Breakthrough For Local Market Device Labeling
Executive Summary
Rules on the labeling needs for medtech products entering the Swiss market have been eased in what is seen by the local industry as a victory for pragmatism.
You may also be interested in...
No MRA Means Switzerland’s Seamless IVDs Trade With The EU Is At An End
The EU’s full implementation of the In Vitro Diagnostic Regulation on 26 May has put the Swiss IVD industry on a "third country" footing with the EU, as happened in 2021 for medical devices. The two parties’ mutual recognition agreement for all medtech products has ceased to apply. A renewed MRA is not likely for several years.
German Reimbursement Reform: Hospitals Hit Back
Architects of the major reform of secondary care reimbursement have asked for the input of hospitals just once, the DKG hospital federation complains. Meanwhile, many clinics are reportedly facing insolvency later this year.
The E in ESG: Medtechs Are Getting To Grips With The ‘True Purpose’ Of Carbon Zero
BD and Boston Scientific exemplify the approach of “big medtech” as it knuckles down to meet global climate change responsibilities. But the industry will have to work together with health systems to achieve the larger race to zero goals – especially those of scope 3.